InvestorsHub Logo

Garden Rose

05/07/21 9:24 AM

#1312 RE: janice shell #1309

I think you better re-read my response. (Also, below I list tons of studies showing the effetiveness of hydroxy).

Apparently you are confusing the studies. Here is how to break it down:

1. Studies that are conducted on hospitalized advanced Covid patients -
Hydroxy not effective.

2. Studies that are conducted on those with Covid where the virus has
advanced to serious respiratory infection --
Hydroxy not effective.

3. Hydroxy used upon the onset of Covid (within 1 to 5 days) --
Hydroxy very effective and highly effective in reducing
hospitalizations
.

Here's how and when to use hydroxy effectively:

https://www.amjmed.com/article/S0002-9343(20)30673-2/fulltext

Additionally "For over a year now there has been ever growing, extensive, and overwhelming clinical evidence that HCQ, when used within the first five days of symptom onset, produces a sharp and statistically significant reduction in COVID hospitalization and mortality. Adverse cardiac events are not a factor.

By July of 2020, seven controlled, well-conducted clinical studies had been conducted in Brazil (1353 patients); France (425 nursing-home and clinic patients); New Jersey (1,247 outpatients); Andorra (100 long-term care patients); and 7,892 patients across Saudi Arabia. All of these studies used the premise of the early treatment of high-risk mortality COVID outpatients, and all showed 50% or higher reductions in hospitalization and death. Not a single fatal cardiac arrhythmia was attributable to HCQ in over 11,000 outpatient outcomes. 14

In addition, a summary analysis of five randomized controlled clinical trials involving 5,577 patients in the United States and Spain, also found that outpatient use of HCQ for early treatment of COVID-19, significantly reduced the composite of hospitalization and death. 15
Again, adverse cardiac events were not a factor." See https://drstevenhatfill.com/how-a-single-point-failure-destroyed-the-national-pandemic-plan/

Our own government "refused to publish the ground-breaking June 2020 study showing that early HCQ hospital use is associated with a 51% reduction in mortality. These results were quickly reproduced by a Mt Sinai study and by a later Spanish study which showed a 66% reduction in COVID mortality." See https://drstevenhatfill.com/how-a-single-point-failure-destroyed-the-national-pandemic-plan/